Halia CEO David Bearss, Ph.D., to Present and Participate in Panel Discussion at Obesity Innovation Therapeutics Summit 2024
LEHI, Utah, Dec. 5, 2024 /PRNewswire/ -- Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for chron…
